Let me tell you, folks, when it comes to pediatric large-vessel occlusion, the situation has been, frankly, not great. But, we’ve seen some incredible things, some fantastic studies showing us the light at the end of the tunnel – mechanical thrombectomy. It’s safe, it’s feasible, and it’s showing real benefits for our kids. Now, there’s been a bit of uncertainty, a little question mark hanging over us about its role in pediatric M2 occlusions. But, hold on, we’ve got something big here.

We looked at six pediatric patients, a mix of brave young individuals, mostly boys, with ages ranging from just under a year to 16 years old. And guess what? After undergoing thrombectomy, these kids showed excellent clinical outcomes. We’re talking top-notch results, with pediatric mRS scores of 0 to 1 at 3 months and even at their last follow-ups, which, by the way, ranged up to an impressive 72 months.

Now, making decisions in these cases, it’s not a walk in the park. It’s serious business. But the key, the absolute key, is having a multidisciplinary team on board. These discussions, these team huddles during acute management, they’re crucial, they’re what make the difference.

So, let me be clear: when it comes to tackling pediatric M2 occlusions, it’s about bringing the best to the table, making those informed decisions, and, let me tell you, the results, they’re going to be huge, absolutely huge.